Emricasan
N/A
Report date: 2025/10/24 17:59:47
NMEFirst In Class
Base Information
Drug NameEmricasan
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[19]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIdun Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesIdun PharmaceuticalsNovartis AgHistogen Inc +[6]
Active IndicationsN/A
Inactive Indications +[19]